Sign up to access historical data
Similar companies
| Company | Est. Transaction Value | |
|---|---|---|
 |
Abbott LaboratoriesABT |
$14,000 |
 |
Tempus AITEM |
$160,000 |
 |
ProgynyPGNY |
-$8,000 |
 |
SolventumSOLV |
-$41,000 |
 |
Waters CorporationWAT |
$24,000 |
Trades by US Politicians
| Politician | Filing Date | Type | Size |
|---|---|---|---|
| Julie Johnson | Nov 3, 2025 | Sell | $1K - $15K |
| Gil Cisneros | Jan 24, 2025 | Sell | $1K - $15K |
| Ro Khanna | Nov 15, 2024 | Buy | $1K - $15K |
| Earl Blumenauer Democrat | Apr 4, 2024 | Sell | $1K - $15K |
| Rohit Khanna Democrat | Feb 13, 2024 | Sell | $1K - $15K |
| Rohit Khanna Democrat | Feb 13, 2024 | Sell | $1K - $15K |
FAQ - Congress Trading
Julie Johnson sold Quest Diagnostics shares most recently on November 3, 2025.
Ro Khanna has bought the most DGX stock in the last 2 years, with an estimated value of $8,000.
Rohit Khanna has sold the most DGX stock in the last 2 years, with an estimated value of $16,000.
The net value of trades by US politicians for Quest Diagnostics in the last 2 years is negative, amounting to -$32,000. This suggests that US politicians do not believe in the success of the company for various reasons.
Over the last 2 years, insider transactions for Quest Diagnostics have largely consisted of selling shares, which could suggest various personal or financial motivations among insiders. The higher number of sales might require investors to investigate further, considering politicians might have insights or reasons not immediately apparent to the public.
Monitoring US politicians' stock trades is valuable because they may have inside information about upcoming policies that could affect stock values, providing investors with valuable clues for making informed decisions.
